Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon

British Journal of Haematology

Volumn 180, Issue 1, 2018, Pages 134-146

  Wonkam, Ambroise ^a   Mnika, Khuthala ^a   Ngo Bitoungui, Valentina J ^b   Chetcha Chemegni, Bernard ^b   Chimusa, Emile R ^a   Dandara, Collet ^a   Kengne, Andre P ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

acute vaso occlusive painful crises; Africa; Cameroon; genetics; sickle cell disease

Indexed keywords

CATECHOL METHYLTRANSFERASE; FATTY ACID AMIDASE; GLUCURONOSYLTRANSFERASE 2B7; HEME OXYGENASE 1; HEMOGLOBIN F; HEMOGLOBIN VARIANT;

ADOLESCENT; ADRB2 GENE; ADULT; AGE; APOL1 GENE; ARTICLE; BCL11A GENE; BLOOD TRANSFUSION; BODY MASS; CACNA2D3 GENE; CAMEROON; CHILD; COMT GENE; CONSULTATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRD2 GENE; ERYTHROCYTE COUNT; ESTIMATED GLOMERULAR FILTRATION RATE; FAAH GENE; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HBA1 GENE; HBA2 GENE; HBS1L MYB GENE; HEALTH CARE UTILIZATION; HEREDITY; HMOX1 GENE; HOSPITALIZATION; HUMAN; KCNS1 GENE; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OPRM1 GENE; PAIN; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SICKLE CELL ANEMIA; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; UGT2B7 GENE; VASCULAR DISEASE; VASOOCCLUSIVE CRISIS; ALLELE; BLOOD; CASE CONTROL STUDY; COMPLICATION; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; HAPLOTYPE; KIDNEY FUNCTION TEST; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; MUTATION; PATIENT ATTITUDE; PRESCHOOL CHILD; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; ANEMIA, SICKLE CELL; CAMEROON; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE INDICES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HEMOGLOBINS, ABNORMAL; HOSPITALIZATION; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MUTATION; PAIN; PATIENT ACCEPTANCE OF HEALTH CARE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; QUANTITATIVE TRAIT LOCI; YOUNG ADULT;

EID: 85037617557     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.15011     Document Type: Article

References (52)

1. Ataga, K.I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T.H., Knight-Madden, J., Alvarez, O.A., Gordeuk, V.R., Gualandro, S., Colella, M.P., Smith, W.R., Rollins, S.A., Stocker, J.W. & Rother, R.P. (2017) Crizanlizumab for the prevention of pain crises in sickle cell disease. New England Journal of Medicine, 376, 429–439.
2. Baddam, S., Aban, I., Hilliard, L., Howard, T., Askenazi, D. & Lebensburger, J.D. (2017) Acute kidney injury during a pediatric sickle cell vasoocclusive pain crisis. Pediatric Nephrology, 32, 1451–1456.
3. Baeza-Richer, C., Arroyo-Pardo, E., Blanco-Rojo, R., Toxqui, L., Remacha, A., Vaquero, M.P. & López-Parra, A.M. (2015) Genetic contribution to iron status: SNPs related to iron deficiency anaemia and fine mapping of CACNA2D3 calcium channel subunit. Blood Cells, Molecules, and Diseases, 55, 273–280.
4. Ballas, S.K., Gupta, K. & Adams-Graves, P. (2012) Sickle cell pain: a critical reappraisal. Blood, 120, 3647–3656.
5. Bean, C.J., Boulet, S.L., Ellingsen, D., Pyle, M.E., Barron-Casella, E.A., Casella, J.F., Payne, A.B., Driggers, J., Trau, H.A., Yang, G., Jones, K., Ofori-Acquah, S.F., Hooper, W.C. & Debaun, M.R. (2012) Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood, 120, 3822–3828.
6. Belfer, I., Youngblood, V., Darbari, D.S., Wang, Z., Diaw, L., Freeman, L., Desai, K., Dizon, M., Allen, D. & Cunnington, C. (2014) A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anaemia. American Journal of Hematology, 89, 187–193.
7. Bitoungui, V.J.N., Pule, G.D., Hanchard, N., Ngogang, J. & Wonkam, A. (2015) Beta-globin gene haplotypes among cameroonians and review of the global distribution: is there a case for a single sickle mutation origin in Africa?. Omics: A Journal of Integrative Biology, 19, 171–179.
8. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., Mcmahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anaemia. New England Journal of Medicine, 332, 1317–1322.
9. Chaturvedi, S., Bhatnagar, P., Bean, C.J., Milton, J.N., Casella, J.F., Barron-Casella, E., Arking, D.E. & DeBaun, M.R. (2017) Genome-wide association study to identify variants associated with vaso-occlusive pain in sickle cell anaemia. Blood, 130, 686–688 pii: blood-2017-02-769661.
10. Costigan, M., Belfer, I., Griffin, R.S., Dai, F., Barrett, L.B., Coppola, G., Wu, T., Kiselycznyk, C., Poddar, M. & Lu, Y. (2010) Multiple chronic pain states are associated with a common amino acid–changing allele in KCNS1. Brain, 133, 2519–2527.
11. Darbari, D.S., Van Schaik, R.H., Capparelli, E.V., Rana, S., Mccarter, R. & Van Den Anker, J. (2008) UGT2B7 promoter variant_ 840G> A contributes to the variability in hepatic clearance of morphine in patients with sickle cell disease. American Journal of Hematology, 83, 200–202.
12. Darbari, D.S., Onyekwere, O., Nouraie, M., Minniti, C.P., Luchtman-Jones, L., Rana, S., Sable, C., Ensing, G., Dham, N. & Campbell, A. (2012) Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anaemia. The Journal of Pediatrics, 160, 286–290.
13. Darbari, D.S., Wang, Z., Kwak, M., Hildesheim, M., Nichols, J., Allen, D., Seamon, C., Peters-Lawrence, M., Conrey, A. & Hall, M.K. (2013) Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anaemia cohort study. PLoS One, 8, e79923.
14. Elmariah, H., Garrett, M.E., Castro, L.M., Jonassaint, J.C., Ataga, K.I., Eckman, J.R., Ashley-Koch, A.E. & Telen, M.J. (2014) Factors associated with survival in a contemporary adult sickle cell disease cohort. American Journal of Hematology, 89, 530–535.
15. Eyler, C.E., Jackson, T., Elliott, L.E., De Castro, L.M., Jonassaint, J., Ashley-Koch, A. & Telen, M.J. (2008) beta(2)-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion. British Journal of Haematology, 14, 105–108.
16. Galarneau, G., Coady, S., Garrett, M.E., Jeffries, N., Puggal, M., Paltoo, D., Soldano, K., Guasch, A., Ashley-Koch, A.E., Telen, M.J., Kutlar, A., Lettre, G. & Papanicolaou, G.J. (2013) Genecentric association study of acute chest syndrome and painful crisis in sickle cell disease patients. Blood, 122, 434–442.
17. Geard, A., Pule, G.D., Chetcha Chemegni, B., Ngo Bitoungui, V.J., Kengne, A.P., Chimusa, E.R. & Wonkam, A. (2017) Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. British Journal of Haematology, https://doi.org/10.1111/bjh.14724
18. Guasch, A., Zayas, C.F., Eckman, J.R., Muralidharan, K., Zhang, W. & Elsas, L.J. (1999) Evidence that microdeletions in the alpha globin gene protect against the development of sickle cell glomerulopathy in humans. Journal of the American Society of Nephrology, 10, 1014–1019.
19. Gurdasani, D., Carstensen, T., Tekola-Ayele, F., Pagani, L., Tachmazidou, I., Hatzikotoulas, K., Karthikeyan, S., Iles, L., Pollard, M.O. & Choudhury, A. (2015) The African genome variation project shapes medical genetics in Africa. Nature, 517, 327–332.
20. Higgs, D.R., Aldridge, B.E., Lamb, J., Clegg, J.B., Weatherall, D.J., Hayes, R.J., Grandison, Y., Lowrie, Y., Mason, K.P. & Serjeant, B.E. (1982) The interaction of alpha-thalassemia and homozygous sickle-cell disease. New England Journal of Medicine, 306, 1441–1446.
21. Hoots, W.K. & Shurin, S.B. (2012) Future directions of sickle cell disease research: the NIH perspective. Pediatric Blood & Cancer, 59, 353–357.
22. Hoppe, C., Jacob, E., Styles, L., Kuypers, F., Larkin, S. & Vichinsky, E. (2017) Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. British Journal of Haematology, 177, 620–629.
23. Hu, X., Jhun, E.H., Yao, Y., He, Y., Molokie, R.E., Wilkie, D.J. & Wang, Z.J. (2016) IL1A rs1800587 associates with chronic noncrisis pain in sickle cell disease. Pharmacogenomics, 17, 1999–2006.
24. Jhun, E., He, Y., Yao, Y., Molokie, R.E., Wilkie, D.J. & Wang, Z.J. (2014) Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease. Anesthesia and Analgesia, 119, 1201–1207.
25. Jhun, E.H., Yao, Y., He, Y., Kyle, M.A., Wilkie, D.J., Molokie, R.E. & Wang, Z.J. (2015) Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell disease. Pharmacogenomics, 16, 1795–1806.
26. Joly, P., Gagnieu, M., Bardel, C., Francina, A., Pondarre, C. & Martin, C. (2012) Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients. American Journal of Hematology, 87, 534–536.
27. Kanter, J. & Kruse-Jarres, R. (2013) Management of sickle cell disease from childhood through adulthood. Blood Reviews, 27, 279–287.
28. Kato, G.J., Steinberg, M.H. & Gladwin, M.T. (2017) Intravascular hemolysis and the pathophysiology of sickle cell disease. The Journal of Clinical Investigation, 127, 750–760.
29. Keller, S., Yang, M., Treadwell, M.J. & Hassell, K.L. (2017) Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS_ to ASCQMe SM. Health and Quality of Life Outcomes, 15, 117.
30. Leonardo, F.C., Brugnerotto, A.F., Domingos, I.F., Fertrin, K.Y., Albuquerque, D.M., Bezerra, M.A., Aráujo, A.S., Saad, S.T., Cost A.F.F. & Menze L.S. (2016) Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci. British Journal of Haematology, 173, 456–460.
31. Lettre, G., Sankaran, V.G., Bezerra, M.A., Araujo, A.S., Uda, M., Sanna, S., Cao, A., Schlessinger, D., Costa, F.F., Hirschhorn, J.N. & Orkin, S.H. (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with foetal haemoglobin levels and pain crises in sickle cell disease. Proceedings of the National Academy of Sciences of the United States of America, 105, 11869–11874.
32. Machado, R.F., Barst, R.J., Yovetich, N.A., Hassell, K.L., Kato, G.J., Gordeuk, V.R., Gibbs, J.S., Little, J.A., Schraufnagel, D.E., Krishnamurti, L., Girgis, R.E., Morri S.C.R., Rosenzweig, E.B., Badesch, D.B., Lanzkron, S., Onyekwere, O., Castro, O.L., Sachdev, V., Waclawiw, M.A., Woolso N R., Goldsmith, J.C. & Gladwin, M.T.; Walk-PHaSST Investigators and Patients. (2011) Hospitalisation for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood, 118, 855–864.
33. McMillan, J.E., Meier, E.R., Winer, J.C., Coco, M., Daymont, M., Long, S. & Jacobs, B.R. (2015) Clinical and geographic characterization of 30-day readmissions in pediatric sickle cell crisis patients. Hospital Pediatrics, 5, 423–431.
34. Meier, E.R., Fasano, R.M. & Levett, P.R. (2017) A systematic review of the literature for severity predictors in children with sickle cell anemia. Blood Cells, Molecules, and Diseases, 65, 86–94.
35. Mendoncá, T., Oliveira, M., Vasconcelos, L., Pereira, L., Moura, P., Bezerra, M., Santos, M., Aráujo, A. & Cavalcanti, M. (2010) Association of variant alleles of MBL2 gene with vasoocclusive crisis in children with sickle cell anaemia. Blood Cells, Molecules, and Diseases, 44, 224–228.
36. Mnika, K., Pule, G.D., Dandara, C. & Wonkam, A. (2016) An expert review of pharmacogenomics of sickle cell disease therapeutics: not yet ready for global precision medicine. OMICS: A Journal of Integrative Biology, 20, 565–574.
37. Mtatiro, S.N., Singh, T., Rooks, H., Mgaya, J., Marik I H., Soka, D., Mmbando, B., Msak I E., Kolder, I. & Thein, S.L. (2014) Genome wide association study of foetal haemoglobin in sickle cell anaemia in Tanzania. PLoS One, 9, e111464.
38. Njamnshi, A., Mbong, E., Wonkam, A., Ongolo-Zogo, P., Djientcheu, V., Sunjoh, F., Wiysonge, C., Sztajzel, R., Mbanya, D. & Blackett, K.N. (2006) The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon. Journal of the Neurological Sciences, 250, 79–84.
39. Owusu-Ansah, A., Ihunnah, C.A., Walker, A.L. & Ofori-Acquah, S.F. (2016) Inflammatory targets of therapy in sickle cell disease. Translational Research, 167, 281–297.
40. Piel, F.B., Pati LA.P., Howes, R.E., Nyangir IO.A., Gething, P.W., Dewi, M., Temperley, W.H., Williams, T.N., Weatherall, D.J. & Hay, S.I. (2013) Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. The Lancet, 381, 142–151.
41. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E. & Kinney, T.R. (1991) Pain in sickle cell disease: rates and risk factors. New England Journal of Medicine, 325, 11–16.
42. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H. & Klug, P.P. (1994) Mortality in sickle cell disease–life expectancy and risk factors for early death. New England Journal of Medicine, 330, 1639–1644.
43. Rees, D.C., Williams, T.N. & Gladwin, M.T. (2010) Sickle-cell disease. The Lancet, 376, 2018–2031.
44. Rumaney, M.B., Bitoungui, V.J.N., Vorster, A.A., Ramesar, R., Kengne, A.P., Ngogang, J. & Wonkam, A. (2014) The co-inheritance of alpha-thalassemia and sickle cell anaemia is associated with better haematological indices and lower consultations rate in Cameroonian patients and could improve their survival. PLoS One, 9, e100516.
45. Saiki, R.K., Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H.A. & Arnheim, N. (1985) Enzymatic amplification of b-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anaemia. Science, 230, 1350–1354.
46. Sheehan, V.A., Luo, Z., Flanagan, J.M., Howard, T.A., Thompson, B.W., Wang, W.C., Kutlar, A. & Ware, R.E. (2013) Genetic modifiers of sickle cell anaemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. American Journal of Hematology, 88, 571–576.
47. Tarer, V., Etienne-Julan, M., Diara, J., Belloy, M.S., Mukizi-Mukaza, M., Elion, J. & Romana, M. (2006) Sickle cell anaemia in Guadeloupean children: pattern and prevalence of acute clinical events. European Journal of Haematology, 76, 193–199.
48. Weatherall, D. & Clegg, J. (2001) Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization, 79, 704–712.
49. Wonkam, A., Mba, C.Z., Mbanya, D., Ngogang, J., Ramesar, R. & Angwafo, F.F. III (2014a) Psychosocial stressors of sickle cell disease on adult patients in Cameroon. Journal of Genetic Counseling, 23, 948–956.
50. Wonkam, A., Bitoungu IV.J.N., Vorster, A.A., Ramesar, R., Cooper, R.S., Tayo, B., Lettre, G. & Ngogang, J. (2014b) Association of variants at BCL11A and HBS1L-MYB with haemoglobin F and hospitalisation rates among sickle cell patients in Cameroon. PLoS One, 9, e92506.
51. World Health Organization. (2010) Trends in Maternal Mortality: 1990 to 2008. Estimates Developed by WHO, UNICEF, UNFPA and the World Bank. World Health Organization, Geneva, Switzerland.
52. Zivot, A., Apollonsky, N., Gracely, E. & Raybagkar, D. (2017) Body mass index and the association with vaso-occlusive crises in pediatric sickle cell disease. Journal of Pediatric Hematology/Oncology, 39, 314–317.